Pfizer Sheds Lipitor Buyers' Class Action In Antitrust MDL
A New Jersey federal judge on Friday dismissed an antitrust suit in multidistrict litigation challenging a purportedly anti-competitive patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Ltd. over Lipitor, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article